Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

2022658 citationsJournal Articlebronze Open Access

Authors

Matthew E. Oster · Centers for Disease Control and Prevention

David K. Shay · Centers for Disease Control and Prevention

John R. Su · Centers for Disease Control and Prevention

Julianne Gee · Centers for Disease Control and Prevention

C. Buddy Creech · Vanderbilt University Medical Center

Karen R. Broder · Centers for Disease Control and Prevention

Kathryn M. Edwards

Abstract

Based on passive surveillance reporting in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased across multiple age and sex strata and was highest after the second vaccination dose in adolescent males and young men. This risk should be considered in the context of the benefits of COVID-19 vaccination.

Topics & Keywords

Viral Infections and Immunology Research SARS-CoV-2 and COVID-19 Research Cardiac Structural Anomalies and Repair

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 327, Issue 4, pp. 331-331

DOI: 10.1001/jama.2021.24110

Field-Weighted Citation Impact: 105.22